Join the 200th Anniversary Celebration

Original Article

Incidence and Prognosis of Syncope

Elpidoforos S. Soteriades, M.D., Jane C. Evans, D.Sc., Martin G. Larson, Sc.D., Ming Hui Chen, M.D., Leway Chen, M.D., Emelia J. Benjamin, M.D., and Daniel Levy, M.D.

N Engl J Med 2002; 347:878-885September 19, 2002

Abstract

Background

Little is known about the epidemiology and prognosis of syncope in the general population.

Methods

We evaluated the incidence, specific causes, and prognosis of syncope among women and men participating in the Framingham Heart Study from 1971 to 1998.

Results

Of 7814 study participants followed for an average of 17 years, 822 reported syncope. The incidence of a first report of syncope was 6.2 per 1000 person-years. The most frequently identified causes were vasovagal (21.2 percent), cardiac (9.5 percent), and orthostatic (9.4 percent); for 36.6 percent the cause was unknown. The multivariable-adjusted hazard ratios among participants with syncope from any cause, as compared with those who did not have syncope, were 1.31 (95 percent confidence interval, 1.14 to 1.51) for death from any cause, 1.27 (95 percent confidence interval, 0.99 to 1.64) for myocardial infarction or death from coronary heart disease, and 1.06 (95 percent confidence interval, 0.77 to 1.45) for fatal or nonfatal stroke. The corresponding hazard ratios among participants with cardiac syncope were 2.01 (95 percent confidence interval, 1.48 to 2.73), 2.66 (95 percent confidence interval, 1.69 to 4.19), and 2.01 (95 percent confidence interval, 1.06 to 3.80). Participants with syncope of unknown cause and those with neurologic syncope had increased risks of death from any cause, with multivariable-adjusted hazard ratios of 1.32 (95 percent confidence interval, 1.09 to 1.60) and 1.54 (95 percent confidence interval, 1.12 to 2.12), respectively. There was no increased risk of cardiovascular morbidity or mortality associated with vasovagal (including orthostatic and medication-related) syncope.

Conclusions

Persons with cardiac syncope are at increased risk for death from any cause and cardiovascular events, and persons with syncope of unknown cause are at increased risk for death from any cause. Vasovagal syncope appears to have a benign prognosis.

Media in This Article

Figure 2Overall Survival of Participants with Syncope, According to Cause, and Participants without Syncope.
Figure 1Incidence Rates of Syncope According to Age and Sex.
Article

Syncope, defined as a sudden loss of consciousness associated with the inability to maintain postural tone, followed by spontaneous recovery, is relatively common. However, the epidemiology and prognosis of syncope in the community have not been well described. Data are limited on the cumulative incidence1,2 and lifetime prevalence3-7 of syncope.

Although syncope has many possible causes, several studies have used three categories of cause — cardiac, noncardiac, and unknown — to examine the prognosis of syncope prospectively.8 Previous studies of syncope were conducted in emergency departments,9-12 in general hospitals,13-17 and among highly selected subgroups of patients with syncope of unknown cause.18-27 Little is known about the prognosis of syncope due to specific causes in the general population. We conducted a study to evaluate the incidence and prognosis of syncope due to specific causes among participants in the Framingham Heart Study.

Methods

Study Sample

The study sample consisted of participants in the original Framingham Heart Study and in the Framingham Offspring Study who underwent routine clinical examinations between 1971 and 1998. The details of the study design and selection criteria have been described elsewhere.28,29 We examined all reports of syncope in study participants undergoing a qualifying clinical examination. Syncope reports were coded as “yes,” “no,” or “maybe.” A committee of physicians reviewed all episodes coded as “maybe.” Possible episodes of syncope were coded as definite only if the participant's chart contained additional medical information confirming a syncopal event that had not been available at the time of the initial clinical evaluation. We excluded 120 equivocal reports of syncope, 101 reports of syncope from participants who had not had an examination within four years before the index report (to minimize possible recall bias), 47 reports of syncope due to head trauma, and 7 reports of syncope with incomplete records. All participants undergoing examination in the Framingham Heart Study provided written informed consent; the content and procedures of the examinations were reviewed and approved by the institutional review board of Boston Medical Center.

Incidence

The overall incidence rate of syncope and the incidence rates for syncope with specific causes were calculated by dividing the number of participants with syncope by the total number of person-years of follow-up in each subgroup. For the calculation of incidence rates in different age groups, we categorized participants according to their age halfway between the time of the clinical examination preceding the report of syncope and the time of the index examination for syncope. We calculated the cumulative incidence by assuming a constant incidence over time, using the following formula:

cumulative incidence = 1 – e–IΔt,

where e is the natural logarithm constant (2.718), I denotes the incidence rate, and Δt denotes the duration of follow-up.

Causes of Syncope

The cause of syncope was assigned according to a clinical diagnosis made by two physicians (an internist and a cardiologist) on the basis of documentation provided by the examining Framingham Heart Study physician and information obtained during routine clinic visits from the medical history, physical examination, and electrocardiographic examination. In addition, the physicians reviewed all available hospital and outpatient medical records pertaining to each instance of syncope. Generally, the discharge diagnosis was used for participants evaluated at an outside hospital, as long as this diagnosis was supported by associated records. For other participants, the diagnosis of the examining Framingham Heart Study physician was used. If a cardiovascular cause was suspected, a second evaluation was performed by another Framingham Heart Study physician. If these evaluations did not agree, the physician reviewers evaluated available data to assign a cause.

Reports of syncope were classified into eight categories according to cause: cardiac cause (including ischemia and arrhythmias), unknown cause, stroke or transient ischemic attack, seizure disorder, vasovagal cause, orthostatic cause, medication, and other, infrequent causes (including cough syncope, micturition syncope, and situational syncope). These eight categories were reduced to four etiologic categories for the outcome analysis: cardiac cause, unknown cause, neurologic cause (including syncope due to stroke, transient ischemic attack, and seizure), and vasovagal or other cause (including vasovagal syncope, orthostatic syncope, medication-induced syncope, and syncope due to other identified causes). Secondary analyses were also performed after we excluded syncope due to seizure from the category of neurologic syncope. When a participant did not seek medical attention for syncope and the history, physical examination, and electrocardiographic findings were not indicative of any of the specific causes, the cause was classified as unknown. The physicians who confirmed the diagnoses of syncope and assigned the causes were unaware of subsequent outcomes.

Recurrence of Syncope

The first episode of syncope reported by a participant during a clinical examination was treated as the first syncopal event. If more than one syncopal event was reported between clinic visits, we counted only one episode of syncope. Episodes reported at subsequent clinical examinations were considered recurrences of syncope.

End Points

The participants in the follow-up sample were followed for up to 25 years. A prospective cohort design was used to study three outcomes in relation to syncope: death from any cause, myocardial infarction or death from coronary heart disease (which included both sudden and nonsudden death from coronary heart disease), and fatal or nonfatal stroke. All outcome events were reviewed with the use of all pertinent available medical records and adjudicated on the basis of previously published criteria.30 Data from 95 participants who reported syncope during their last index examination were excluded from the outcome analysis, because no follow-up data were available for them. For each participant with syncope, we randomly selected two participants without syncope who underwent clinical examination at the Framingham Heart Study clinic during the same examination cycle, matched according to age and sex.

Statistical Analysis

All statistical analyses were performed with SAS software (version 6.12).31 The age-, sex-, and category-specific incidence rates of syncope were computed. The survival rates among participants with syncope due to specific causes were examined with Kaplan–Meier survival curves.32 Age- and multivariable-adjusted Cox proportional-hazard regression models33 were used to analyze the risk of each outcome of interest among participants with cause-specific syncope (four etiologic categories) as compared with participants without syncope. We evaluated the outcomes of interest by using dummy variables for each of the four etiologic categories. Multivariable models were adjusted for age, sex, presence or absence of a history of cardiovascular disease (myocardial infarction, coronary heart disease, stroke or transient ischemic attack, congestive heart failure, atrial fibrillation, and intermittent claudication), smoking status, presence or absence of hypertension, systolic blood pressure, presence or absence of diabetes, total cholesterol level, heart rate, and use or nonuse of cardiac medication, including antihypertensive medications. Hypertension was a dichotomous variable defined as a systolic blood pressure of at least 140 mm Hg, a diastolic blood pressure of at least 90 mm Hg, or current use of antihypertensive medication. The presence or absence of a history of cardiovascular disease, smoking status, presence or absence of diabetes, use or nonuse of cardiac medication, and normal or elevated total cholesterol level (with an elevated level defined as at least 200 mg per deciliter [5.2 mmol per liter]) were also included in the model as dichotomous variables. Age, systolic blood pressure, and heart rate were included as continuous variables.

Results

We followed 7814 participants (3563 men and 4251 women) for an average of 17.0 years (median, 19.1; interquartile range, 10.6 to 23.6) during 133,164 person-years of follow-up. The participants had a mean (±SD) age of 51.1±14.4 years (range, 20 to 96). A total of 822 participants (348 men and 474 women; mean age, 65.8 years) reported syncope. After excluding participants without follow-up (those whose first episode of syncope was reported at the last index examination), we included 727 participants in the outcome analysis.

Incidence

The overall incidence rate of a first report of syncope was 6.2 per 1000 person-years. The incidence rates increased with age, with a sharp rise at 70 years (Figure 1Figure 1Incidence Rates of Syncope According to Age and Sex.). The age-adjusted incidence was 7.2 per 1000 person-years among both men and women. The age-adjusted incidence rate among participants with cardiovascular disease was nearly twice that among participants without cardiovascular disease (10.6 vs. 6.4 per 1000 person-years). The incidence rates of first reports of cardiac syncope, syncope of unknown cause, syncope due to stroke or transient ischemic attack, syncope due to seizure, vasovagal syncope, orthostatic syncope, medication-induced syncope, and syncope of other causes were 0.59, 2.26, 0.26, 0.30, 1.31, 0.58, 0.42, and 0.47 per 1000 person-years, respectively. Assuming a constant incidence rate over time, we calculated a 10-year cumulative incidence of syncope of 6 percent.

Causes of Syncope

The distributions of causes in men and women, respectively, were as follows: cardiac causes (13.2 percent and 6.7 percent), unknown cause (31.0 percent and 40.7 percent), stroke or transient ischemic attack (4.3 percent and 4.0 percent), seizure disorder (7.2 percent and 3.2 percent), vasovagal cause (19.8 percent and 22.2 percent), orthostatic cause (8.6 percent and 9.9 percent), medication (6.3 percent and 7.2 percent), and other causes (9.5 percent and 6.1 percent). The causes of syncope according to cardiovascular disease status at base line are shown in Table 1Table 1Causes of Syncope According to Sex and the Presence or Absence of Cardiovascular Disease at Base Line.. Overall, 56 percent of participants with a syncopal episode reported seeing a doctor or visiting a hospital for evaluation.

Recurrence of Syncope

Five hundred seventy participants (78.4 percent) reported only one episode of syncope. One hundred fifty-seven participants (21.6 percent) reported one or more recurrences of syncope (17.6 percent reported one recurrence, 3.3 percent two recurrences, and 0.7 percent three or more recurrences). The rate of recurrence among participants with a history of syncope was higher than the incidence of a first episode of syncope among those without such a history (multivariable-adjusted hazard ratio, 23.2; 95 percent confidence interval, 14.2 to 37.9). The risk of recurrence was especially high among participants with cardiac syncope (multivariable-adjusted hazard ratio, 30.0; 95 percent confidence interval, 14.9 to 60.3).

Follow-up

The characteristics of the 2181 study participants who were eligible for follow-up are shown in Table 2Table 2Characteristics of the Follow-up Sample.. As compared with those without syncope, participants with syncope of any cause, and in particular those with cardiac syncope, were more likely to have a history of coronary artery disease or cerebrovascular disease and to take cardiac or antihypertensive medications. During a mean follow-up of 8.6 years (median, 7.7), there were 847 deaths from all causes, 263 myocardial infarctions or deaths from coronary heart disease, and 178 fatal or nonfatal strokes.

Participants with cardiac syncope had lower survival than those without syncope, as shown by Kaplan–Meier survival curves (Figure 2Figure 2Overall Survival of Participants with Syncope, According to Cause, and Participants without Syncope.). Multivariable-adjusted Cox proportional-hazard regression models showed that the risk of death was increased by 31 percent among all participants with syncope and was doubled among participants with cardiac syncope, as compared with those without syncope. Syncope of unknown cause and neurologic syncope were associated with an increased risk of death from any cause, and neurologic syncope was also associated with a threefold risk of stroke (Table 3Table 3Hazard Ratios for the Outcomes of Interest in Participants with Syncope as Compared with Participants without Syncope.). Vasovagal syncope (including orthostatic syncope, medication-related syncope, and syncope due to other, infrequent causes) was not associated with an increased risk of any of the major outcomes.

Secondary analyses were also performed to examine the relations of cause-specific syncope to the outcomes of interest after exclusion of data from 40 participants who had syncope due to seizures. The findings were similar to the results shown in Table 3, except that the association between neurologic syncope and death from any cause was no longer statistically significant (hazard ratio, 1.24; 95 percent confidence interval, 0.81 to 1.89).

Because cardiac syncope might have been preferentially diagnosed in participants with syncope who were already known to have cardiovascular disease, we also performed secondary analyses stratified according to the presence or absence of known cardiovascular disease. The results were similar in the two groups (data not shown). In addition, to address the possibility that syncope of unknown cause might have been associated with poor outcomes because persons with this diagnosis received a different level of medical care, we performed analyses stratified according to whether the participant sought or did not seek medical care for the syncopal event (130 and 131 participants, respectively). The data from 11 participants were excluded from this analysis because information on whether they sought medical care was not available. As compared with participants without syncope, participants with this diagnosis who sought medical care had a higher risk of death from any cause (multivariable-adjusted hazard ratio, 1.47; 95 percent confidence interval, 1.14 to 1.90), although their risk of myocardial infarction or death from coronary heart disease was not significantly elevated (adjusted hazard ratio, 1.07; 95 percent confidence interval, 0.63 to 1.83). Participants with syncope of unknown cause who did not seek medical care had a higher risk of myocardial infarction or death from coronary heart disease (adjusted hazard ratio, 1.60; 95 percent confidence interval, 1.04 to 2.48), but their risk of death from any cause was not significantly elevated (adjusted hazard ratio, 1.23; 95 percent confidence interval, 0.94 to 1.60).

Discussion

In this population-based study, we found a similar incidence of syncope in men and women. The incidence was almost doubled in participants with a history of cardiovascular disease. Mortality was about 30 percent higher among all participants with syncope and among those with syncope of unknown cause than among those without syncope; this increase was due largely to an increased risk of death from myocardial infarction or coronary heart disease. Cardiac syncope doubled the risk of death from any cause and increased the risk of fatal and nonfatal cardiovascular events. Neurologic syncope was associated with an increased risk of death from any cause and an increased risk of stroke.

Although the incidence of syncope rose sharply with advancing age, the age-specific annual incidence of syncope for those above 80 years of age in our study (about 2 percent) was considerably lower than that reported by Lipsitz et al. (6 percent) in an elderly institutionalized population (mean age, 87 years).1 Overall, 37 percent of syncopal events in our sample were due to unknown causes. The distribution of causes of syncope that we observed is similar to that reported elsewhere.34,35 For example, Linzer et al. reported that, on average, 34 percent of syncopal episodes could not be assigned to an etiologic category after a standard evaluation with a detailed history taking, physical examination, and electrocardiography.36

Our findings are consistent with those of Kapoor15 in suggesting that cardiac syncope is associated with increased risks of premature death and cardiovascular events. Whether or not there was a history of cardiovascular disease, we found that participants with a diagnosis of cardiac syncope were more likely to have a poor outcome than those without syncope.

Several other studies have evaluated the outcome of syncope of unknown cause.18-27 The results suggested that among subjects with syncope that was initially classified as being of unknown cause and that was later found to have a cardiac cause, the risk of death was higher than in the general population. Electrophysiological studies and electrocardiographic monitoring in highly selected subgroups of patients37-41 have suggested that 45 to 80 percent of cases of syncope classified as being of unknown cause could be assigned a cardiac cause. It is likely that many participants in our study with syncope of unknown cause had unrecognized cardiac syncope, with its attendant risk of an adverse outcome.

Participants with syncope of neurologic cause had more than twice as high a risk of fatal or nonfatal stroke as subjects without syncope. The increased risk is probably attributable to a high risk of stroke, often recurrent, in participants with neurologic syncope who had preexisting cerebrovascular disease.

Among participants with syncope of identified cause, by far the largest subgroup consisted of those with syncope of vasovagal or other causes, including orthostatic and medication-induced syncope. Among these participants we found no increase in the risk of death from any cause or in the risk of myocardial infarction or death from coronary heart disease, in comparison to those without syncope, even though the statistical power to detect such increases was high (96 percent power to detect a 50 percent increase in the risk of death from any cause; 84 percent power to detect a 75 percent increase in the risk of myocardial infarction or death from coronary heart disease).

This study involved a population-based sample free of selection bias and an extensive period of follow-up. However, some limitations should be noted. We attempted to minimize misclassification of participants according to whether or not they had previously had an episode of syncope by excluding those who had not undergone a clinical examination within four years before an examination at which they reported syncope. However, a four-year interval may constitute a long recall period, especially for older patients. Differential recall bias is unlikely to have affected our findings, because our prospective cohort design ensured that exposures were ascertained before the outcomes. Problems with recall, however, may have contributed to underestimation of the incidence of syncope and hazard ratios for adverse outcomes associated with this diagnosis.42

Another concern is possible misclassification of participants according to etiologic categories of syncope.43 Although we did not develop explicit criteria for confirming a given cause of syncope, we sought to minimize misclassification by having diagnoses assigned by the consensus of two physician reviewers, unaware of the study outcomes, who reviewed all related outside records and Framingham Heart Study examination records. The presence of other risk factors for cardiovascular disease or the presence of cardiovascular disease may have contributed to cardiovascular risk among participants with syncope, but our findings persisted after we adjusted for these factors in multivariable models and in secondary analyses stratified according to the presence or absence of known cardiovascular disease. Finally, our study sample consisted almost entirely of middle-aged and older white men and women, and thus the results may not be generalizable to other populations.

Our findings suggest that persons with cardiac syncope constitute a high-risk group predisposed to morbidity and premature mortality from cardiovascular disease who should be monitored closely. Persons with syncope of unknown cause appear to constitute a mixed group at increased risk for death; this result suggests that further diagnostic testing may be warranted in these patients. The increased risk of stroke in participants with neurologic syncope may be attributable to preexisting cerebrovascular disease. Our results also provide reassurance that vasovagal syncope has a benign prognosis.

Supported by grants (N01-HC-38038 and NS-17950) from the National Heart, Lung, and Blood Institute.

Source Information

From the National Heart, Lung, and Blood Institute Framingham Heart Study, Framingham, Mass. (E.S.S., J.C.E., M.G.L., M.H.C., L.C., E.J.B., D.L.); the Departments of Cardiology and Preventive Medicine, Boston Medical Center, Boston (E.J.B.); the National Heart, Lung, and Blood Institute, Bethesda, Md. (D.L.); and the Division of Cardiology, Beth Israel Deaconess Medical Center, Boston (D.L.).

Address reprint requests to Dr. Levy at the Framingham Heart Study, 73 Mt. Wayte Ave., Suite 2, Framingham, MA 01702-5827.

References

References

  1. 1

    Lipsitz LA, Wei JY, Rowe JW. Syncope in an elderly, institutionalised population: prevalence, incidence, and associated risk. Q J Med 1985;55:45-54
    Web of Science | Medline

  2. 2

    Savage DD, Corwin L, McGee DL, Kannel WB, Wolf PA. Epidemiologic features of isolated syncope: the Framingham Study. Stroke 1985;16:626-629
    CrossRef | Web of Science | Medline

  3. 3

    Dermksian G, Lamb LE. Syncope in a population of healthy young adults: incidence, mechanisms, and significance. JAMA 1958;160:1200-1207

  4. 4

    Dermksian G, Lamb LE. Cardiac arrhythmias in experimental syncope. JAMA 1958;168:1623-1630
    Web of Science | Medline

  5. 5

    Lamb LE, Green H, Combs JJ, Chessman SA, Hammond J. Incidence of loss of consciousness in 1,980 Air Force personnel. Aerosp Med 1960;31:973-988
    Medline

  6. 6

    Williams RL, Allen PD. Loss of consciousness: incidence, causes and electroencephalographic findings. Aerosp Med 1962;33:545-551
    Medline

  7. 7

    Murdoch BD. Loss of consciousness in healthy South African men: incidence, causes and relationship to EEG abnormality. S Afr Med J 1980;57:771-774
    Medline

  8. 8

    Kapoor WN, Karpf M, Wieand S, Peterson JR, Levey GS. A prospective evaluation and follow-up of patients with syncope. N Engl J Med 1983;309:197-204
    Full Text | Web of Science | Medline

  9. 9

    Day SC, Cook EF, Funkenstein H, Goldman L. Evaluation and outcome of emergency room patients with transient loss of consciousness. Am J Med 1982;73:15-23
    CrossRef | Web of Science | Medline

  10. 10

    Eagle KA, Black HR, Cook EF, Goldman L. Evaluation of prognostic classifications for patients with syncope. Am J Med 1985;79:455-460
    CrossRef | Web of Science | Medline

  11. 11

    Lee RT, Cook EF, Day SC, Goldman L. Long-term survival after transient loss of consciousness. J Gen Intern Med 1988;3:337-343
    CrossRef | Web of Science | Medline

  12. 12

    Martin TP, Hanusa BH, Kapoor WN. Risk stratification of patients with syncope. Ann Emerg Med 1997;29:459-466
    CrossRef | Web of Science | Medline

  13. 13

    Silverstein MD, Singer DE, Mulley AG, Thibault GE, Barnett GO. Patients with syncope admitted to medical intensive care units. JAMA 1982;248:1185-1189
    CrossRef | Web of Science | Medline

  14. 14

    Houdent C, Morcamp D, Sereni D, et al. Pronostic à un an des lipothymies et pertes de connaissance brèves après 65 ans: etude multicentrique de 188 cas. Presse Med 1988;17:626-629
    Web of Science | Medline

  15. 15

    Kapoor WN. Evaluation and outcome of patients with syncope. Medicine (Baltimore) 1990;69:160-175
    Web of Science | Medline

  16. 16

    Kapoor WN, Hanusa BH. Is syncope a risk factor for poor outcomes? Comparison of patients with and without syncope. Am J Med 1966;100:646-655
    CrossRef | Web of Science

  17. 17

    Getchell WS, Larsen GC, Morris CD, McAnulty JH. Epidemiology of syncope in hospitalized patients. J Gen Intern Med 1999;14:677-687
    CrossRef | Web of Science | Medline

  18. 18

    Morady F, Shen E, Schwartz A, et al. Long-term follow-up of patients with recurrent unexplained syncope evaluated by electrophysiologic testing. J Am Coll Cardiol 1983;2:1053-1059
    CrossRef | Web of Science | Medline

  19. 19

    Doherty JU, Pembrook-Rogers D, Grogan EW, et al. Electrophysiologic evaluation and follow-up characteristics of patients with recurrent unexplained syncope and presyncope. Am J Cardiol 1985;55:703-708
    CrossRef | Web of Science | Medline

  20. 20

    Olshansky B, Mazuz M, Martins JB. Significance of inducible tachycardia in patients with syncope of unknown origin: a long-term follow-up. J Am Coll Cardiol 1985;5:216-223
    CrossRef | Web of Science | Medline

  21. 21

    Kapoor WN, Cha R, Peterson JR, Wieand HS, Karpf M. Prolonged electrocardiographic monitoring in patients with syncope: importance of frequent or repetitive ventricular ectopy. Am J Med 1987;82:20-28
    CrossRef | Web of Science | Medline

  22. 22

    Krol RB, Morady F, Flaker GC, et al. Electrophysiologic testing in patients with unexplained syncope: clinical and noninvasive predictors of outcome. J Am Coll Cardiol 1987;10:358-363
    CrossRef | Web of Science | Medline

  23. 23

    Bass EB, Elson JJ, Fogoros RN, Peterson J, Arena VC, Kapoor WM. Long-term prognosis of patients undergoing electrophysiologic studies for syncope of unknown origin. Am J Cardiol 1988;62:1186-1191
    CrossRef | Web of Science | Medline

  24. 24

    Kushner JA, Kou WH, Kadish AH, Morady F. Natural history of patients with unexplained syncope and a nondiagnostic electrophysiologic study. J Am Coll Cardiol 1989;14:391-396
    CrossRef | Web of Science | Medline

  25. 25

    Sra JS, Anderson AJ, Sheikh SH, et al. Unexplained syncope evaluated by electrophysiologic studies and head-up tilt testing. Ann Intern Med 1991;114:1013-1019
    Web of Science | Medline

  26. 26

    Gouello JP, Victor J, Dupuis JM, Tadei A. Exploration électrophysiologique pour le diagnostic et le pronostic des syncopes de cause indéterminée. Presse Med 1995;24:387-392
    Web of Science | Medline

  27. 27

    Olshansky B, Hahn EA, Hartz VL, Prater SP, Mason JW. Clinical significance of syncope in the Electrophysiologic Study versus Electrocardiographic Monitoring (ESVEM) trial. Am Heart J 1999;137:878-886
    CrossRef | Web of Science | Medline

  28. 28

    Dawber TR, Meadors GF, Moore FE Jr. Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health 1951;41:279-286
    CrossRef | Web of Science

  29. 29

    Kannel WB, Feinleib M, McNamara PM, Garrison RJ, Castelli WP. An investigation of coronary heart disease in families: the Framingham Offspring Study. Am J Epidemiol 1979;110:281-290
    Web of Science | Medline

  30. 30

    Kannel WB, Wolf PA, Garrison RJ. Framingham Heart Study, section 34: some risk factors related to the annual incidence of cardiovascular disease and death in pooled repeated biennial measurements: 30 year follow-up. Bethesda, Md.: National Institutes of Health, 1987. (NIH publication no. 87-2703.)

  31. 31

    SAS/STAT software: changes and enhancements through release 6.12. Cary, N.C.: SAS Institute, 1997:413-20, 873-948.

  32. 32

    Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481
    CrossRef | Web of Science

  33. 33

    Cox DR. Regression models and life-tables. J R Stat Soc [B] 1972;34:187-220

  34. 34

    Martin GJ, Adams SL, Martin HG, Mathews J, Zull D, Scanlon PJ. Prospective evaluation of syncope. Ann Emerg Med 1984;13:499-504
    CrossRef | Web of Science | Medline

  35. 35

    Kapoor WN. Workup and management of patients with syncope. Med Clin North Am 1995;79:1153-1170
    Web of Science | Medline

  36. 36

    Linzer M, Yang EH, Estes NA III, Wang P, Vorperian VR, Kapoor WN. Diagnosing syncope. Part 1. Value of history, physical examination, and electrocardiography: Clinical Efficacy Assessment Project of the American College of Physicians. Ann Intern Med 1997;126:989-996
    Web of Science | Medline

  37. 37

    Hess DS, Morady F, Scheinman MM. Electrophysiologic testing in the evaluation of patients with syncope of undetermined origin. Am J Cardiol 1982;50:1309-1315
    CrossRef | Web of Science | Medline

  38. 38

    Teichman SL, Felder SD, Matos JA, Kim SG, Waspe LE, Fisher JD. The value of electrophysiologic studies in syncope of undetermined origin: report of 150 cases. Am Heart J 1985;110:469-479
    CrossRef | Web of Science | Medline

  39. 39

    Linzer M, Pritchett EL, Pontinen M, McCarthy E, Divine GW. Incremental diagnostic yield of loop electrocardiographic recorders in unexplained syncope. Am J Cardiol 1990;66:214-219
    CrossRef | Web of Science | Medline

  40. 40

    Moazez F, Peter T, Simonson J, Mandel WJ, Vaughn C, Gang E. Syncope of unknown origin: clinical, noninvasive, and electrophysiologic determinants of arrhythmia induction and symptom recurrence during long-term follow-up. Am Heart J 1991;121:81-88
    CrossRef | Web of Science | Medline

  41. 41

    Linzer M, Yang EH, Estes NA III, Wang P, Vorperian VR, Kapoor WN. Diagnosing syncope. Part 2. Unexplained syncope: Clinical Efficacy Assessment Project of the American College of Physicians. Ann Intern Med 1997;127:76-86
    Web of Science | Medline

  42. 42

    Barry D. Differential recall bias and spurious associations in case/control studies. Stat Med 1996;15:2603-2616
    CrossRef | Web of Science | Medline

  43. 43

    Dosemeci M, Wacholder S, Lubin JH. Does nondifferential misclassification of exposure always bias a true effect toward the null value? Am J Epidemiol 1990;132:746-748
    Web of Science | Medline

Citing Articles (175)

Citing Articles

  1. 1

    A. D. Krahn, C. A. Morillo, T. Kus, B. Manns, S. Rose, M. Brignole, R. S. Sheldon. (2012) Empiric pacemaker compared with a monitoring strategy in patients with syncope and bifascicular conduction block--rationale and design of the Syncope: Pacing or Recording in ThE Later Years (SPRITELY) study. Europace
    CrossRef

  2. 2

    M.A. Aydin, S. Willems. (2012) Management und Therapie der vasovagalen Synkope. Der Kardiologe
    CrossRef

  3. 3

    Francesc Planas Comes, Ludmila San Vicente, Francesc Planas Ayma, Joan Viles, Albert Planas, Ana Serrado, Edgardo Kaplinsky, Montserrat Altimira. (2012) Eficacia de un protocolo para el diagnóstico y tratamiento del síncope en una población no seleccionada. Medicina Clínica 138:1, 7-10
    CrossRef

  4. 4

    Jacobus J. C. M. Romme, Nynke Dijk, Ingeborg K. Go-Schön, Gerty Casteelen, Wouter Wieling, Johannes B. Reitsma. (2011) Association between psychological complaints and recurrence of vasovagal syncope. Clinical Autonomic Research 21:6, 373-380
    CrossRef

  5. 5

    Salvatore Rosanio, Ernst R. Schwarz, David L. Ware, Antonio Vitarelli. (2011) Syncope in adults: Systematic review and proposal of a diagnostic and therapeutic algorithm. International Journal of Cardiology
    CrossRef

  6. 6

    Fabrizio D'Ascenzo, Giuseppe Biondi-Zoccai, Matthew J. Reed, Gelareh Z. Gabayan, Masaru Suzuki, Giorgio Costantino, Raffaello Furlan, Andrea Del Rosso, Francois P. Sarasin, Benjamin C. Sun, Maria Grazia Modena, Fiorenzo Gaita. (2011) Incidence, etiology and predictors of adverse outcomes in 43,315 patients presenting to the Emergency Department with syncope: An international meta-analysis. International Journal of Cardiology
    CrossRef

  7. 7

    MYUNG H. BAE, JUNG K. KANG, NA Y. KIM, WON S. CHOI, KYUN H. KIM, SUN H. PARK, JANG H. LEE, DONG H. YANG, HUN S. PARK, YONGKEUN CHO, SHUNG C. CHAE, JAE-EUN JUN. (2011) Clinical Characteristics of Defecation and Micturition Syncope Compared with Common Vasovagal Syncope. Pacing and Clinical Electrophysiologyno-no
    CrossRef

  8. 8

    PETER MITRO, PETER KIRSCH, GABRIEL VALOČIK, PAVOL MURíN. (2011) Clinical History in the Diagnosis of the Cardiac Syncope-The Predictive Scoring System. Pacing and Clinical Electrophysiology 34:11, 1480-1485
    CrossRef

  9. 9

    Paul Angaran, George J. Klein, Raymond Yee, Allan C. Skanes, Lorne J. Gula, Peter Leong-Sit, Andrew D. Krahn. (2011) Syncope. Neurologic Clinics 29:4, 903-925
    CrossRef

  10. 10

    A. Ungar, G. Galizia, A. Morrione, C. Mussi, G. Noro, L. Ghirelli, G. Masotti, F. Rengo, N. Marchionni, P. Abete. (2011) Two-year morbidity and mortality in elderly patients with syncope. Age and Ageing 40:6, 696-702
    CrossRef

  11. 11

    Jacobus JCM Romme, Johannes B Reitsma, Catherine N Black, Nancy Colman, Rob JPM Scholten, Wouter Wieling, Nynke Van Dijk, Nynke Van Dijk. 2011. Drugs and pacemakers for vasovagal, carotid sinus and situational syncope. .
    CrossRef

  12. 12

    Rui Providência, Joana Silva, Paula Mota, José Nascimento, António Leitão-Marques. (2011) Transient loss of consciousness in young adults. International Journal of Cardiology 152:1, 139-143
    CrossRef

  13. 13

    F.J. Gíl Gómez, J.A. Sevillano Fernández, A.I. Castuera Gil, M. Fernández Cardona. (2011) Mareo y síncope. Medicine - Programa de Formación Médica Continuada Acreditado 10:87, 5890-5895
    CrossRef

  14. 14

    Juna Misiri, Shawn Candler, Fred M. Kusumoto. (2011) Evaluation of Syncope and Palpitations in Women. Journal of Women's Health 20:10, 1505-1515
    CrossRef

  15. 15

    Antonio Franco Folino, Federico Migliore, Alberto Porta, Sergio Cerutti, Sabino Iliceto, Gianfranco Buja. (2011) Syncope while driving: Pathophysiological features and long-term follow-up. Autonomic Neuroscience
    CrossRef

  16. 16

    J. C. Pachon M, E. I. Pachon M, M. Z. Cunha Pachon, T. J. Lobo, J. C. Pachon M, T. G. Santillana P. (2011) Catheter ablation of severe neurally meditated reflex (neurocardiogenic or vasovagal) syncope: cardioneuroablation long-term results. Europace 13:9, 1231-1242
    CrossRef

  17. 17

    J. Cooke, S. Carew, A. Costelloe, T. Sheehy, C. Quinn, D. Lyons. (2011) The changing face of orthostatic and neurocardiogenic syncope with age. QJM 104:8, 689-695
    CrossRef

  18. 18

    Marietta Hugyecz, Éva Mracskó, Péter Hertelendy, Eszter Farkas, Ferenc Domoki, Ferenc Bari. (2011) Hydrogen supplemented air inhalation reduces changes of prooxidant enzyme and gap junction protein levels after transient global cerebral ischemia in the rat hippocampus. Brain Research 1404, 31-38
    CrossRef

  19. 19

    Mark S. Link, Derek V. Exner, Mark Anderson, Michael Ackerman, Amin Al-Ahmad, Bradley P. Knight, Steven M. Markowitz, Elizabeth S. Kaufman, David Haines, Samuel J. Asirvatham, David J. Callans, J. Paul Mounsey, Frank Bogun, Sanjiv M. Narayan, Andrew D. Krahn, Suneet Mittal, Jagmeet Singh, John D. Fisher, Sumeet S. Chugh. (2011) HRS Policy Statement: Clinical Cardiac Electrophysiology Fellowship Curriculum: Update 2011. Heart Rhythm 8:8, 1340-1356
    CrossRef

  20. 20

    Michael Kühne, Beat Schaer, Christian Sticherling, Stefan Osswald. (2011) Holter Monitoring in Syncope: Diagnostic Yield in Octogenarians. Journal of the American Geriatrics Society 59:7, 1293-1298
    CrossRef

  21. 21

    James Quinn, Daniel McDermott. (2011) Electrocardiogram Findings in Emergency Department Patients with Syncope. Academic Emergency Medicine 18:7, 714-718
    CrossRef

  22. 22

    B.J. Steinhoff, S. Bilic, A.M. Staack, E. Hodenberg. (2011) Differenzialdiagnostische Klärung durch implantierten „Loop“-Rekorder. Zeitschrift für Epileptologie
    CrossRef

  23. 23

    K. Seidl, W. Scheidt, C. Pfafferott. (2011) Reflexsynkope. Herzschrittmachertherapie + Elektrophysiologie 22:2, 93-98
    CrossRef

  24. 24

    Andrea Radtke, Thomas Lempert, Michael Brevern, Maria Feldmann, Franziska Lezius, Hannelore Neuhauser. (2011) Prevalence and complications of orthostatic dizziness in the general population. Clinical Autonomic Research 21:3, 161-168
    CrossRef

  25. 25

    R. Schimpf, C. Veltmann, M. Borggrefe. (2011) Orthostatische Hypotension. Herzschrittmachertherapie + Elektrophysiologie 22:2, 99-106
    CrossRef

  26. 26

    H.-H. Ebert, C. Walter, H. Volkmann. (2011) Vom Bewusstseinsverlust zur Synkope. Herzschrittmachertherapie + Elektrophysiologie 22:2, 65-71
    CrossRef

  27. 27

    Salah S. Al-Zaiti, Mohamad K. Khasawneh, Mary G. Carey. (2011) Syncope: An Uncommon Presentation of Ischemic Cardiomyopathy. The Journal for Nurse Practitioners 7:5, 385-391
    CrossRef

  28. 28

    Adam Darowski, Robert Whiting. (2011) Cardiovascular medication and falls. Reviews in Clinical Gerontology 21:02, 170-179
    CrossRef

  29. 29

    Joseph F. Drazkowski, Matthew Hoerth. 2011. The Evaluation of Nonepileptic Paroxysmal Events. , 99-111.
    CrossRef

  30. 30

    GANGADHAR MALASANA, MICHELE BRIGNOLE, MARCOS DACCARETT, RANDALL SHERWOOD, MOHAMED H. HAMDAN. (2011) The Prevalence and Cost of the Faint and Fall Problem in the State of Utah. Pacing and Clinical Electrophysiology 34:3, 278-283
    CrossRef

  31. 31

    Sony Jacob, Mehrdad Toosi, Aditya S. Bharadwaj, Javier Sala Mercado, Luis Afonso. (2011) ‘UnSTEADy'ness in elderly: Unexplained syncope induced by tachycardia in elderly with AV nodal disease and LV diastolic dysfunction. International Journal of Cardiology
    CrossRef

  32. 32

    Adrian A. Maung, Lewis J. Kaplan, Kevin M. Schuster, Dirk C. Johnson, Kimberly A. Davis. (2011) Routine or Protocol Evaluation of Trauma Patients With Suspected Syncope is Unnecessary. The Journal of Trauma: Injury, Infection, and Critical Care 70:2, 428-432
    CrossRef

  33. 33

    N. Edvardsson, V. Frykman, R. van Mechelen, P. Mitro, A. Mohii-Oskarsson, J.-L. Pasquie, H. Ramanna, F. Schwertfeger, R. Ventura, D. Voulgaraki, C. Garutti, P. Stolt, N. J. Linker, , M. Ait Said, P. Amman, T. Aronsson, A. Bauer, W. Benzer, V. Bernat, D. Bocker, A. Brandes, P. Breuls, S. Buffler, H. Ebert, A. Ebrahimi, O. Eschen, T. Fahraeus, G. Falck, W. Fehske, R. Frank, V. Frykman, F. Gadler, G. Gehling, M. Geist, J. Gunther, M. Gutmann, H. Hartog, H. Hartog, S. Jensen, W. Kainz, J. Kautzner, W. Kiowski, B. Kjellman, H. Klomps, H. Krappinger, P. Lercher, J. Lindstrom, M. Lukat, Z. Machacova, C. Magnusson, F. Maru, J. Melichercik, A. Militianu, T. Minarik Nemocnice, P. Mitro, A. Mohii-Oskarsson, H. Molgaard, C. Nimeth, T. Nordt, M. Novak, K. Nyman, J.- L. Pasquie, J. Plomp, A. Podczeck-Schweighofer, H. Ramanna, J. M. Rigollaud, C. Rorsman, A. Rotzer, T. Salo, N. Samnieh, F. Schwertfeger, G. Strupp, H. Sunthorn, S. Trinks, I. C. van Gelder, R. van Mechelen, R. Ventura, E. Vester, S. Viskin, P. Visman, J. Vlasinova, I. Westbom, W. B. Winkler, J. Woltmann. (2011) Use of an implantable loop recorder to increase the diagnostic yield in unexplained syncope: results from the PICTURE registry. Europace 13:2, 262-269
    CrossRef

  34. 34

    Orla Collins, Rose Anne Kenny. (2011) Association between syncope and cognitive impairment. Aging Health 7:1, 143-153
    CrossRef

  35. 35

    L. Barnett, M. W. S. Martin, J. Todd, S. Smith, M. Cobb. (2011) A retrospective study of 153 cases of undiagnosed collapse, syncope or exercise intolerance: the outcomes. Journal of Small Animal Practice 52:1, 26-31
    CrossRef

  36. 36

    Kaoru Tanno, Onuki Tatsuya. (2011) Implantable Loop Recorder for a Patient with Unexplained Syncope. Journal of Arrhythmia 27:2, 158-159
    CrossRef

  37. 37

    Peter Vanbrabant, Jean Gillet, Frank Buntinx, Stefaan Bartholomeeusen, Bert Aertgeerts. (2011) Incidence and outcome of first syncope in primary care: A retrospective cohort study. BMC Family Practice 12:1, 102
    CrossRef

  38. 38

    B Bień, J Wilmańska, W Jańczak, A Wojskowicz, A Kasiukiewicz, K Klimiuk, M Toczyńska-Silkiewicz, E Gułaj, B Kuprjanowicz. (2011) Syncope and near-syncope as a multifactorial problem in geriatric inpatients: Systemic hypotension is an underrated predictor for syncope exclusively. Advances in Medical Sciences 1:-1, 1-9
    CrossRef

  39. 39

    H.H. Klein, A. Krämer, B.M. Pieske, H.-J. Trappe, H. Vries. (2010) Fahreignung bei kardiovaskulären Erkrankungen. Der Kardiologe 4:6, 441-473
    CrossRef

  40. 40

    V.K. Marrison, A. Fletcher, S.W. Parry. (2010) The older patient with syncope: Practicalities and controversies. International Journal of Cardiology
    CrossRef

  41. 41

    Saumy Sharma, Trieu Ho, Bharat Kantharia. 2010. Not Seizure but Syncope. .
    CrossRef

  42. 42

    Roman Pfister, Jens Hagemeister, Susanne Esser, Martin Hellmich, Erland Erdmann, Christian A. Schneider. (2010) NT-pro-BNP for diagnostic and prognostic evaluation in patients hospitalized for syncope. International Journal of Cardiology
    CrossRef

  43. 43

    Dan Sorajja, Win-Kuang Shen. (2010) Driving Guidelines and Restrictions in Patients With a History of Cardiac Arrhythmias, Syncope,or Implantable Devices. Current Treatment Options in Cardiovascular Medicine 12:5, 443-456
    CrossRef

  44. 44

    PIETRO GUIDA, MASSIMO IACOVIELLO, CINZIA FORLEO, SANDRO SORRENTINO, AGATA PUZZOVIVO, MARICA RODIO, FRANCESCA DE PASCALIS, CATALDO BALDUCCI, MARGHERITA SARLO, STEFANO FAVALE. (2010) Nitrate-Potentiated Head-Up Tilt Testing in Older Patients: Outcomes, Hemodynamic Responses and Prodrome Recognition. Pacing and Clinical Electrophysiology 33:10, 1210-1216
    CrossRef

  45. 45

    Ram S. Duriseti, Margaret L. Brandeau. (2010) Cost-Effectiveness of Strategies for Diagnosing Pulmonary Embolism Among Emergency Department Patients Presenting With Undifferentiated Symptoms. Annals of Emergency Medicine 56:4, 321-332.e10
    CrossRef

  46. 46

    F. Boesebeck, S. Freermann, C. Kellinghaus, S. Evers. (2010) Misdiagnosis of epileptic and non-epileptic seizures in a neurological intensive care unit. Acta Neurologica Scandinavica 122:3, 189-195
    CrossRef

  47. 47

    Chad Kessler, Jenny M. Tristano, Robert De Lorenzo. (2010) The Emergency Department Approach to Syncope: Evidence-based Guidelines and Prediction Rules. Emergency Medicine Clinics of North America 28:3, 487-500
    CrossRef

  48. 48

    A. M. Humm, C. J. Mathias. (2010) Abnormal cardiovascular responses to carotid sinus massage also occur in vasovagal syncope - implications for diagnosis and treatment. European Journal of Neurology 17:8, 1061-1067
    CrossRef

  49. 49

    Helen Ouyang, James Quinn. (2010) Diagnosis and Evaluation of Syncope in the Emergency Department. Emergency Medicine Clinics of North America 28:3, 471-485
    CrossRef

  50. 50

    G. W. Duncan, M. P. Tan, J. L. Newton, P. Reeve, S. W. Parry. (2010) Vasovagal syncope in the older person: differences in presentation between older and younger patients. Age and Ageing 39:4, 465-470
    CrossRef

  51. 51

    THIAGO da ROCHA RODRIGUES, EDUARDO B. STERNICK, MARIA da CONSOLAÇÃO VIEIRA MOREIRA. (2010) Epilepsy or Syncope? An Analysis of 55 Consecutive Patients with Loss of Consciousness, Convulsions, Falls, and No EEG Abnormalities. Pacing and Clinical Electrophysiology 33:7, 804-813
    CrossRef

  52. 52

    Paul S. Gibson, Rshmi Khurana, Winnie W. Sia. 2010. Approach to Presyncope and Syncope in Pregnancy. , 715-718.
    CrossRef

  53. 53

    G. Baron-Esquivias, J. Martinez-Alday, A. Martin, A. Moya, R. Garcia-Civera, M. Paz Lopez-Chicharro, M. Martin-Mendez, C. del Arco, P. Laguna. (2010) Epidemiological characteristics and diagnostic approach in patients admitted to the emergency room for transient loss of consciousness: Group for Syncope Study in the Emergency Room (GESINUR) study. Europace 12:6, 869-876
    CrossRef

  54. 54

    Massimo Iacoviello, Cinzia Forleo, Pietro Guida, Marco Matteo Ciccone, Sandro Sorrentino, Valentina D’Andria, Mariligia Panunzio, Stefano Favale. (2010) Clinical predictors of head-up tilt test outcome during the nitroglycerin phase. Clinical Autonomic Research 20:3, 167-173
    CrossRef

  55. 55

    Hubertus Axer, Martina Axer, Heinrich Sauer, Otto W. Witte, Georg Hagemann. (2010) Falls and gait disorders in geriatric neurology. Clinical Neurology and Neurosurgery 112:4, 265-274
    CrossRef

  56. 56

    Richard N Vest, Michael R Gold. (2010) Risk stratification of ventricular arrhythmias in patients with systolic heart failure. Current Opinion in Cardiology 25:3, 268-275
    CrossRef

  57. 57

    S. W. Parry, I. Matthews. (2010) The implantable loop recorder in older patients with syncope: is sooner better?. Age and Ageing 39:3, 284-285
    CrossRef

  58. 58

    A. Ungar, A. Del Rosso, F. Giada, A. Bartoletti, R. Furlan, F. Quartieri, A. Lagi, A. Morrione, C. Mussi, M. Lunati, G. De Marchi, T. De Santo, N. Marchionni, M. Brignole, . (2010) Early and late outcome of treated patients referred for syncope to emergency department: the EGSYS 2 follow-up study. European Heart Journal
    CrossRef

  59. 59

    P. Kulakowski, M. Lelonek, T. Krynski, B. Bacior, J. Kowalczyk, B. Malkowska, M. Tokarczyk, P. Stypula, T. Pawlik, S. M. Stec. (2010) Prospective evaluation of diagnostic work-up in syncope patients: results of the PL-US registry. Europace 12:2, 230-239
    CrossRef

  60. 60

    M. Brignole, A. Ungar, I. Casagranda, M. Gulizia, M. Lunati, F. Ammirati, A. Del Rosso, M. Sasdelli, M. Santini, R. Maggi, E. Vitale, A. Morrione, G. M. Francese, M. R. Vecchi, F. Giada, . (2010) Prospective multicentre systematic guideline-based management of patients referred to the Syncope Units of general hospitals. Europace 12:1, 109-118
    CrossRef

  61. 61

    Gelareh Z. Gabayan, Stephen F. Derose, Steven M. Asch, Vicki Y. Chiu, Sungching C. Glenn, Carol M. Mangione, Benjamin C. Sun. (2010) Predictors of Short-Term (Seven-Day) Cardiac Outcomes After Emergency Department Visit for Syncope. The American Journal of Cardiology 105:1, 82-86
    CrossRef

  62. 62

    Jungwae Park, Shin Yi Jang, Hye Ran Yim, Young Keun On, June Huh, Dae-Hee Shin, Jun Hyung Kim, June Soo Kim. (2010) Gender Difference in Patients with Recurrent Neurally Mediated Syncope. Yonsei Medical Journal 51:4, 499
    CrossRef

  63. 63

    Ángel Moya, Richard Sutton, Fabrizio Ammirati, Jean-Jacques Blanc, Michele Brignole, Johannes B. Dahm, Jean-Claude Deharo, Jacek Gajek, Knut Gjesdal, Andrew Krahn, Martial Massin, Mauro Pepi, Thomas Pezawas, Ricardo Ruiz Granell, Francois Sarasin, Andrea Ungar, J. Gert van Dijk, Edmond P. Walma, Wouter Wieling, Haruhiko Abe, David G. Benditt, Wyatt W. Decker, Blair P. Grubb, Horacio Kaufmann, Carlos Morillo, Brian Olshansky, Steve W. Parry, Robert Sheldon, Win K. Shen, Alec Vahanian, Angelo Auricchio, Jeroen Bax, Claudio Ceconi, Veronica Dean, Gerasimos Filippatos, Christian Funck-Brentano, Richard Hobbs, Peter Kearney, Theresa McDonagh, Keith McGregor, Bogdan A. Popescu, Zeljko Reiner, Udo Sechtem, Per Anton Sirnes, Michal Tendera, Panos Vardas, Petr Widimsky, Angelo Auricchio, Esmeray Acarturk, Felicita Andreotti, Riccardo Asteggiano, Urs Bauersfeld, Abdelouahab Bellou, Athanase Benetos, Johan Brandt, Mina K. Chung, Pietro Cortelli, Antoine Da Costa, Fabrice Extramiana, José Ferro, Bulent Gorenek, Antti Hedman, Rafael Hirsch, Gabriela Kaliska, Rose Anne Kenny, Keld Per Kjeldse, Rachel Lampert, Henning Mølgard, Rain Paju, Aras Puodziukynas, Antonio Raviele, Pilar Roman, Martin Scherer, Ronald Schondorf, Rosa Sicari, Peter Vanbrabant, Christian Wolpert, José Luis Zamorano. (2009) Guía de práctica clínica para el diagnóstico y manejo del síncope (versión 2009). Revista Española de Cardiología 62:12, 1466.e1-1466.e52
    CrossRef

  64. 64

    , , , , , , , , , , , , , A. Moya, R. Sutton, F. Ammirati, J.-J. Blanc, M. Brignole, J. B. Dahm, J.-C. Deharo, J. Gajek, K. Gjesdal, A. Krahn, M. Massin, M. Pepi, T. Pezawas, R. R. Granell, F. Sarasin, A. Ungar, J. G. van Dijk, E. P. Walma, W. Wieling, , H. Abe, D. G. Benditt, W. W. Decker, B. P. Grubb, H. Kaufmann, C. Morillo, B. Olshansky, S. W. Parry, R. Sheldon, W. K. Shen, , A. Vahanian, A. Auricchio, J. Bax, C. Ceconi, V. Dean, G. Filippatos, C. Funck-Brentano, R. Hobbs, P. Kearney, T. McDonagh, K. McGregor, B. A. Popescu, Z. Reiner, U. Sechtem, P. A. Sirnes, M. Tendera, P. Vardas, P. Widimsky, , A. Auricchio, E. Acarturk, F. Andreotti, R. Asteggiano, U. Bauersfeld, A. Bellou, A. Benetos, J. Brandt, M. K. Chung, P. Cortelli, A. Da Costa, F. Extramiana, J. Ferro, B. Gorenek, A. Hedman, R. Hirsch, G. Kaliska, R. A. Kenny, K. P. Kjeldsen, R. Lampert, H. Molgard, R. Paju, A. Puodziukynas, A. Raviele, P. Roman, M. Scherer, R. Schondorf, R. Sicari, P. Vanbrabant, C. Wolpert, J. L. Zamorano. (2009) Guidelines for the diagnosis and management of syncope (version 2009): The Task Force for the Diagnosis and Management of Syncope of the European Society of Cardiology (ESC). European Heart Journal 30:21, 2631-2671
    CrossRef

  65. 65

    A. J. Turley, M. M. Tynan, C. J. Plummer. (2009) Time to manual activation of implantable loop recorders--implications for programming recording period: a 10-year single-centre experience. Europace 11:10, 1359-1361
    CrossRef

  66. 66

    Helene Höhler. (2009) Der Patient mit Synkope. Medizinische Klinik 104:10, 780-798
    CrossRef

  67. 67

    Rajat Jhanjee, Ilknur Can, David G. Benditt. (2009) Syncope. Disease-a-Month 55:9, 532-585
    CrossRef

  68. 68

    Gianluigi Galizia, Pasquale Abete, Andrea Ungar. (2009) Response to Drs. Fackrell and Mac Mahon. Journal of the American Geriatrics Society 57:9, 1734-1735
    CrossRef

  69. 69

    Bianca D’Antono, Gilles Dupuis, Karine St-Jean, Karine Lévesque, Reginald Nadeau, Peter Guerra, Bernard Thibault, Teresa Kus. (2009) Prospective evaluation of psychological distress and psychiatric morbidity in recurrent vasovagal and unexplained syncope. Journal of Psychosomatic Research 67:3, 213-222
    CrossRef

  70. 70

    J. Gert van Dijk, Roland D. Thijs, David G. Benditt, Wouter Wieling. (2009) A guide to disorders causing transient loss of consciousness: focus on syncope. Nature Reviews Neurology 5:8, 438-448
    CrossRef

  71. 71

    Christian Brandt, Corinna Kramme, Hermann Storm, Bernd Pohlmann-Eden. (2009) Out-of-body experience and auditory and visual hallucinations in a patient with cardiogenic syncope: Crucial role of cardiac event recorder in establishing the diagnosis. Epilepsy & Behavior 15:2, 254-255
    CrossRef

  72. 72

    , M. Brignole, P. Vardas, E. Hoffman, H. Huikuri, A. Moya, R. Ricci, N. Sulke, W. Wieling, , A. Auricchio, G. Y.H. Lip, J. Almendral, P. Kirchhof, E. Aliot, M. Gasparini, F. Braunschweig, , G. Y.H. Lip, J. Almendral, P. Kirchhof, G. L. Botto. (2009) Indications for the use of diagnostic implantable and external ECG loop recorders. Europace 11:5, 671-687
    CrossRef

  73. 73

    David G. Benditt, John T. Nguyen. (2009) Syncope. Journal of the American College of Cardiology 53:19, 1741-1751
    CrossRef

  74. 74

    Qingyou Zhang, Junbao Du, Cheng Wang, Zhongdong Du, Li Wang, Chaoshu Tang. (2009) The diagnostic protocol in children and adolescents with syncope: a multi-centre prospective study. Acta Paediatrica 98:5, 879-884
    CrossRef

  75. 75

    Konstantinos A. Gatzoulis, George Karystinos, Theodoros Gialernios, Helias Sotiropoulos, Andreas Synetos, Polychronis Dilaveris, Skevos Sideris, Ioannis Kalikazaros, Brian Olshansky, Christodoulos I. Stefanadis. (2009) Correlation of Noninvasive Electrocardiography with Invasive Electrophysiology in Syncope of Unknown Origin: Implications from a Large Syncope Database. Annals of Noninvasive Electrocardiology 14:2, 119-127
    CrossRef

  76. 76

    MUHAMMET A. AYDIN, RENKE MAAS, KAI MORTENSEN, TOBIAS STEINIG, HANNO KLEMM, TIM RISIUS, THOMAS MEINERTZ, STEPHAN WILLEMS, CARLOS A. MORILLO, RODOLFO VENTURA. (2009) Predicting Recurrence of Vasovagal Syncope: A Simple Risk Score for the Clinical Routine. Journal of Cardiovascular Electrophysiology 20:4, 416-421
    CrossRef

  77. 77

    F. Sayk, M. Schütt, C. Dodt. (2009) Rationelle risikoadaptierte Synkopendiagnostik in der Notaufnahme. Notfall + Rettungsmedizin 12:2, 95-100
    CrossRef

  78. 78

    Louise R.A. Olde Nordkamp, Nynke van Dijk, Karin S. Ganzeboom, Johannes B. Reitsma, Jan S.K. Luitse, Lukas R.C. Dekker, Win-Kuang Shen, Wouter Wieling. (2009) Syncope prevalence in the ED compared to general practice and population: a strong selection process. The American Journal of Emergency Medicine 27:3, 271-279
    CrossRef

  79. 79

    Roman Pfister, Holger Diedrichs, Robert Larbig, Erland Erdmann, Christian A. Schneider. (2009) NT-pro-BNP for differential diagnosis in patients with syncope. International Journal of Cardiology 133:1, 51-54
    CrossRef

  80. 80

    Amer Alshekhlee, Win-Kuang Shen, Judith Mackall, Thomas C. Chelimsky. (2009) Incidence and Mortality Rates of Syncope in the United States. The American Journal of Medicine 122:2, 181-188
    CrossRef

  81. 81

    Sachin Sud, George J. Klein, Allan C. Skanes, Lorne J. Gula, Raymond Yee, Andrew D. Krahn. (2009) Predicting the cause of syncope from clinical history in patients undergoing prolonged monitoring. Heart Rhythm 6:2, 238-243
    CrossRef

  82. 82

    Jeremiah D. Schuur, Amy Justice. (2009) Measuring Quality of Care in Syncope: Case Definition Affects Reported Electrocardiogram Use but Does Not Bias Reporting. Academic Emergency Medicine 16:1, 40-49
    CrossRef

  83. 83

    Felipe R. Entem, Susana G. Enriquez, Manuel Cobo, Víctor Expósito, Miguel Llano, Marta Ruiz, Juan Jose Olalla, Macarena Otero-Fernandez. (2009) Utility of implantable loop recorders for diagnosing unexplained syncope in clinical practice. Clinical Cardiology 32:1, 28-31
    CrossRef

  84. 84

    MOHAMED H. HAMDAN. (2009) Hemodynamic Monitoring During Syncope: Utility and Limitations. Journal of Cardiovascular Electrophysiology 20:1, 82-84
    CrossRef

  85. 85

    Galizia Galizia, Pasquale Abete, Chiara Mussi, Gabriele Noro, Alessandro Morrione, Assunta Langellotto, Annalisa Landi, Francesco Cacciatore, Giulio Masotti, Franco Rengo, Niccolò Marchionni, Andrea Ungar. (2009) Role of Early Symptoms in Assessment of Syncope in Elderly People: Results from the Italian Group for the Study of Syncope in the Elderly. Journal of the American Geriatrics Society 57:1, 18-23
    CrossRef

  86. 86

    F. Vetta, S. Ronzoni, M. Costarella, C. Donadio, L. Battista, G. Renzulli, G. Gentile, S.M. Zuccaro. (2009) RECURRENT SYNCOPE IN ELDERLY PATIENTS AND TILT TEST TABLE OUTCOME: THE ROLE OF COMORBIDITIES. Archives of Gerontology and Geriatrics 49, 231-236
    CrossRef

  87. 87

    Megumi Horiguchi, Shuntaro Ikeda, Kenichi Yamane, Naoki Izumi, Kosei Ohshima, Ken Ishibashi, Kiyotaka Ohshima, Mareomi Hamada. (2009) A 78-year-old man with unruptured aneurysm of Valsalva found accidentally by syncope during straining. Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 46:3, 259-263
    CrossRef

  88. 88

    Karine St-Jean, Teresa Kus, Gilles Dupuis, Karine Lévesque, Bernard Thibault, Peter G. Guerra, Reginald Nadeau, Bianca D’Antono. (2008) Quality of Life in Patients with Recurrent Vasovagal or Unexplained Syncope: Influence of Sex, Syncope Type and Illness Representations. Applied Research in Quality of Life 3:4, 235-249
    CrossRef

  89. 89

    L. Y. Chen, D. G. Benditt, W.-K. Shen. (2008) Management of Syncope in Adults: An Update. Mayo Clinic Proceedings 83:11, 1280-1293
    CrossRef

  90. 90

    Jacobus JCM Romme, Catherine N Black, Nancy Colman, Rob J.P.M. Scholten, Johannes B Reitsma, Wouter Wieling, Nynke Van Dijk, Jacobus JCM Romme. 2008. Drugs and pacemakers for neurally mediated reflex syncope. .
    CrossRef

  91. 91

    A. Babikar, B. Hynes, N. Ward, P. Oslizok, K. Walsh, D. Keane. (2008) A retrospective study of the clinical experience of the implantable loop recorder in a paediatric setting. International Journal of Clinical Practice 62:10, 1520-1525
    CrossRef

  92. 92

    Michele Brignole. (2008) Experience With Implantable Loop Recorders for Recurrent Unexplained Syncope. Congestive Heart Failure 14, 7-13
    CrossRef

  93. 93

    Regis Schladenhaufen, Steven Feilinger, Marc Pollack, Ronald Benenson, Amy L. Kusmiesz. (2008) Application of San Francisco Syncope Rule in elderly ED patients. The American Journal of Emergency Medicine 26:7, 773-778
    CrossRef

  94. 94

    Andreas Schuchert, Ekhard Wille. (2008) Synkopendiagnostik: wann ambulant, wann stationär?. Herz Kardiovaskuläre Erkrankungen 33:6, 412-418
    CrossRef

  95. 95

    Muhammad Junaid Patel, Nadeem Ullah Khan, Abdul Jawwad Samdani, Muhammad Furqan, Aamir Hameed, Muhammad Shoaib Khan, Syed Imran Ayaz, Muhammad Omer Jamil. (2008) Syncope: experience at a tertiary care hospital in Karachi, Pakistan. International Journal of Emergency Medicine 1:2, 79-83
    CrossRef

  96. 96

    Jacobus J. C. M. Romme, Nynke Dijk, Kimberly R. Boer, Lukas R. C. Dekker, Jan Stam, Johannes B. Reitsma, Wouter Wieling. (2008) Influence of age and gender on the occurrence and presentation of reflex syncope. Clinical Autonomic Research 18:3, 127-133
    CrossRef

  97. 97

    François P. Sarasin, Etienne Pruvot, Martine Louis-Simonet, Olivier W. Hügli, Juan M. Sztajzel, Jürg Schläpfer, Monica Herrera, Johan Graz, Christophe Berchier, Corinne Mischler, Bertrand Yersin. (2008) Stepwise evaluation of syncope: A prospective population-based controlled study. International Journal of Cardiology 127:1, 103-111
    CrossRef

  98. 98

    Haïssaguerre, Michel, Derval, Nicolas, Sacher, Frederic, Jesel, Laurence, Deisenhofer, Isabel, de Roy, Luc, Pasquié, Jean-Luc, Nogami, Akihiko, Babuty, Dominique, Yli-Mayry, Sinikka, De Chillou, Christian, Scanu, Patrice, Mabo, Philippe, Matsuo, Seiichiro, Probst, Vincent, Le Scouarnec, Solena, Defaye, Pascal, Schlaepfer, Juerg, Rostock, Thomas, Lacroix, Dominique, Lamaison, Dominique, Lavergne, Thomas, Aizawa, Yoshifusa, Englund, Anders, Anselme, Frederic, O'Neill, Mark, Hocini, Meleze, Lim, Kang Teng, Knecht, Sebastien, Veenhuyzen, George D., Bordachar, Pierre, Chauvin, Michel, Jais, Pierre, Coureau, Gaelle, Chene, Genevieve, Klein, George J., Clémenty, Jacques, . (2008) Sudden Cardiac Arrest Associated with Early Repolarization. New England Journal of Medicine 358:19, 2016-2023
    Full Text

  99. 99

    James Quinn, Daniel McDermott, Nathan Kramer, Clement Yeh, Michael A. Kohn, Ian Stiell, George Wells. (2008) Death After Emergency Department Visits for Syncope: How Common and Can It Be Predicted?. Annals of Emergency Medicine 51:5, 585-590
    CrossRef

  100. 100

    Brian Olshansky, Jeanne E. Poole, George Johnson, Jill Anderson, Anne S. Hellkamp, Douglas Packer, Daniel B. Mark, Kerry L. Lee, Gust H. Bardy. (2008) Syncope Predicts the Outcome of Cardiomyopathy Patients. Journal of the American College of Cardiology 51:13, 1277-1282
    CrossRef

  101. 101

    PATRICIA A. FRANGINI, FRANK CECCHIN, LIGIA JORDAO, MARIA MARTUSCELLO, MARK E. ALEXANDER, JOHN K. TRIEDMAN, EDWARD P. WALSH, CHARLES I. BERUL. (2008) How Revealing Are Insertable Loop Recorders in Pediatrics?. Pacing and Clinical Electrophysiology 31:3, 338-343
    CrossRef

  102. 102

    Karen M. Stugensky, Gerald W. Neuberg, Mathew S. Maurer. 2008. Evaluation of Syncope in the Elderly Patient. , 673-704.
    CrossRef

  103. 103

    Maw Pin Tan, Steve W. Parry. (2008) Vasovagal Syncope in the Older Patient. Journal of the American College of Cardiology 51:6, 599-606
    CrossRef

  104. 104

    Marvin S. Medow, Julian M. Stewart, Sanjukta Sanyal, Arif Mumtaz, Domenic Sica, William H. Frishman. (2008) Pathophysiology, Diagnosis, and Treatment of Orthostatic Hypotension and Vasovagal Syncope. Cardiology in Review 16:1, 4-20
    CrossRef

  105. 105

    (2008) CrossRef Listing of Deleted DOIs. CrossRef Listing of Deleted DOIs
    CrossRef

  106. 106

    Ries Simons, Hans de Ree, C. Spicer, S. W. Dean. (2008) Fainting Passengers: The Role of Cabin Environment. Journal of ASTM International 5:5, 101651
    CrossRef

  107. 107

    Stephen Perrig, Pierre Jallon. (2008) Is the first seizure truly epileptic?. Epilepsia 49, 2-7
    CrossRef

  108. 108

    Giorgio Costantino, Francesca Perego, Franca Dipaola, Marta Borella, Andrea Galli, Giulia Cantoni, Simonetta Dell’Orto, Simonetta Dassi, Nicola Filardo, Pier Giorgio Duca, Nicola Montano, Raffaello Furlan. (2008) Short- and Long-Term Prognosis of Syncope, Risk Factors, and Role of Hospital Admission. Journal of the American College of Cardiology 51:3, 276-283
    CrossRef

  109. 109

    Àngel Moya i Mitjans, Concepción Alonso Martín. (2008) Manejo de los pacientes con síncope: de las guías a la práctica clínica. Revista Española de Cardiología 61:1, 10-13
    CrossRef

  110. 110

    Felipe Rodríguez-Entem, Susana González-Enríquez, Juan J. Olalla-Antolín, Manuel Cobo-Belaustegui, Víctor Expósito-García, Miguel Llano-Cardenal, Miguel A. Casanova-Martín, Cristina Ruisánchez. (2008) Manejo del síncope en el servicio de urgencias sin ingreso hospitalario: utilidad de un protocolo coordinado con la unidad de arritmias. Revista Española de Cardiología 61:1, 22-28
    CrossRef

  111. 111

    J.A. Andueza Lillo, A. Urbelz Pérez, J.A. Sevillano Fernández, J.C. Cano Ballesteros. (2007) Síncope en Urgencias. Medicine - Programa de Formación Médica Continuada Acreditado 9:90, 5793-5801
    CrossRef

  112. 112

    Paolo Alboni, Maurizio Dinelli, Lorella Gianfranchi, Federico Pacchioni. (2007) Current treatment of recurrent vasovagal syncope: between evidence-based therapy and common sense. Journal of Cardiovascular Medicine 8:10, 835-839
    CrossRef

  113. 113

    Barry Hahn, Sudha Rao, Binita Shah. (2007) Case Report of Precursor B-Cell Lymphoblastic Lymphoma Presenting as Syncope and Cardiac Mass in a Nonimmunocompromised Child. Pediatric Emergency Care 23:8, 576-579
    CrossRef

  114. 114

    Konrad J Werhahn. (2007) Antiepileptic drug use in nursing homes. Aging Health 3:4, 509-516
    CrossRef

  115. 115

    Antonio Franco Folino. (2007) Cerebral Autoregulation and Syncope. Progress in Cardiovascular Diseases 50:1, 49-80
    CrossRef

  116. 116

    Fetnat Fouad-Tarazi, J Calcatti, R Christian, R Armstrong, M Depaul. (2007) Blood Volume Measurement as a Tool in Diagnosing Syncope. The American Journal of the Medical Sciences 334:1, 53-56
    CrossRef

  117. 117

    G. Fröhlig. (2007) Leitlinienkonforme Diagnostik und Therapie der Synkope bei Patienten ohne strukturelle Herzkrankheit. Clinical Research in Cardiology Supplements 2:4, IV38-IV47
    CrossRef

  118. 118

    Oleg Roussanov, Greta Estacio, Maribeth Capuno, Judith Hill, Csaba Kovesdy, Nabil Jarmukli. (2007) Outcomes of Unexplained Syncope in the Elderly. The American Journal of Geriatric Cardiology 16:4, 249-254
    CrossRef

  119. 119

    Maite Vallejo, Antonio G. Hermosillo, Manlio F. Márquez, Alma K. Urquidez, Arturo Sotomayor, Elizabeth Salas, Manuel Cárdenas. (2007) Value of Symptoms to Predict Tilt Testing Outcome in Patients with Clinical Suspicion of Vasovagal Syncope. Archives of Medical Research 38:5, 579-583
    CrossRef

  120. 120

    Benjamin C. Sun, Jerome R. Hoffman, Carol M. Mangione, William R. Mower. (2007) Older Age Predicts Short-Term, Serious Events After Syncope. Journal of the American Geriatrics Society 55:6, 907-912
    CrossRef

  121. 121

    Jacqueline Santhouse, Christine Carrier, Sanjay Arya, Helen Fowler, Susan Duncan. (2007) A Comparison of Self-reported Quality of Life between Patients with Epilepsy and Neurocardiogenic Syncope. Epilepsia 48:5, 1019-1022
    CrossRef

  122. 122

    Oleg Roussanov, Greta Estacio, Maribeth Capuno, S. Jeanne Wilson, Csaba Kovesdy, Nabil Jarmukli. (2007) New-Onset Syncope in Older Adults: Focus on Age and Etiology. The American Journal of Geriatric Cardiology 16:5, 287-294
    CrossRef

  123. 123

    Russell Roberts, Corinne Jeffrey, Gary Carlisle, Elizabeth Brierley. (2007) Prospective investigation of the incidence of falls, dizziness and syncope in haemodialysis patients. International Urology and Nephrology 39:1, 275-279
    CrossRef

  124. 124

    Peter A Smars, Wyatt W Decker, Win-Kuang Shen. (2007) Syncope evaluation in the emergency department. Current Opinion in Internal Medicine 6:2, 115-119
    CrossRef

  125. 125

    J. Stephen Huff, Wyatt W. Decker, James V. Quinn, Andrew D. Perron, Anthony M. Napoli, Suzanne Peeters, Andy S. Jagoda. (2007) Clinical Policy: Critical Issues in the Evaluation and Management of Adult Patients Presenting to the Emergency Department with Syncope. Annals of Emergency Medicine 49:4, 431-444
    CrossRef

  126. 126

    BIJU PAUL, ZBIGNIEW GIEROBA, ARDUINO A. MANGONI. (2007) Influence of Comorbidities and Medication Use on Tilt Table Test Outcome in Elderly Patients. Pacing and Clinical Electrophysiology 30:4, 540-543
    CrossRef

  127. 127

    Sachin Sud, David Massel, George J. Klein, Peter Leong-Sit, Raymond Yee, Allan C. Skanes, Lorne J. Gula, Andrew D. Krahn. (2007) The Expectation Effect and Cardiac Pacing for Refractory Vasovagal Syncope. The American Journal of Medicine 120:1, 54-62
    CrossRef

  128. 128

    Ki-Hoon Park, Sung-Ho Her, Jong-Min Lee, Hee-Jeoung Yoon, Jung-Yeon Chin, Jun-Han Jeon, Ye-Lee Park, Kyong-Rock Do, Yun-Hwa Jung, Seung-Won Jin. (2007) Brain Tumor is a Rare Cause of both Bradycardia and Seizure. Korean Circulation Journal 37:9, 449
    CrossRef

  129. 129

    Masaru Suzuki, Shingo Hori, Naoki Aikawa. (2007) Application of the Recent American Practice Resources for Risk Stratification System for Patients Presenting to a Japanese Emergency Department Because of Syncope. International Heart Journal 48:4, 513-522
    CrossRef

  130. 130

    Makoto Amaki, Kei Kamide, Shin Takiuchi, Shinichiro Niizuma, Takeshi Horio, Yuhei Kawano. (2007) A Case of Neurally Mediated Syncope Induced by Laughter Successfully Treated With Combination of Propranolol and Midodrine. International Heart Journal 48:1, 123-127
    CrossRef

  131. 131

    2007. S. , 186-203.
    CrossRef

  132. 132

    , D.G. Benditt. (2006) The ACCF/AHA Scientific Statement on Syncope. Clinical Autonomic Research 16:6, 363-368
    CrossRef

  133. 133

    David G. Benditt, Brian Olshansky, Wouter Wieling. (2006) The ACCF/AHA Scientific Statement on Syncope Needs Rethinking. Journal of the American College of Cardiology 48:12, 2598-2599
    CrossRef

  134. 134

    TAKEKI SUZUKI, NAOHISA MATSUNAGA, SHUN KOHSAKA. (2006) Diagnostic Patterns in the Evaluation of Patients Hospitalized with Syncope. Pacing and Clinical Electrophysiology 29:11, 1240-1244
    CrossRef

  135. 135

    KARIN S. GANZEBOOM, GIDEON MAIRUHU, JOHANNES B. REITSMA, MARK LINZER, WOUTER WIELING, NYNKE VAN DIJK. (2006) Lifetime Cumulative Incidence of Syncope in the General Population: A Study of 549 Dutch Subjects Aged 35?60 Years. Journal of Cardiovascular Electrophysiology 17:11, 1172-1176
    CrossRef

  136. 136

    Andrea Ungar, Chiara Mussi, Attilio Del Rosso, Gabriele Noro, Pasquale Abete, Loredana Ghirelli, Tommaso Cellai, Annalisa Landi, Gianfranco Salvioli, Franco Rengo, Niccolò Marchionni, Giulio Masotti, . (2006) Diagnosis and Characteristics of Syncope in Older Patients Referred to Geriatric Departments. Journal of the American Geriatrics Society 54:10, 1531-1536
    CrossRef

  137. 137

    Eraldo Occhetta, Miriam Bortnik. (2006) Diagnosis and management of vasovagal syncope in the elderly. Aging Health 2:5, 809-822
    CrossRef

  138. 138

    RAJAT JHANJEE, J. GERT van DIJK, SCOTT SAKAGUCHI, DAVID G. BENDITT. (2006) Syncope in Adults: Terminology, Classification, and Diagnostic Strategy. Pacing and Clinical Electrophysiology 29:10, 1160-1169
    CrossRef

  139. 139

    Begoña Benito, Josep Brugada. (2006) Recurrent syncope: an unusual presentation of Brugada syndrome. Nature Clinical Practice Cardiovascular Medicine 3:10, 573-577
    CrossRef

  140. 140

    Eyal Herzog, Olivier Frankenberger, Walter Pierce, Jonathan S. Steinberg. (2006) The SELF Pathway for the Management of Syncope. Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine 5:3, 173-178
    CrossRef

  141. 141

    Franca Dipaola, Isabella Cucchi, Nicola Filardo, Eleonora Carnovali, Nicola Montano, Raffaello Furlan, Giorgio Costantino. (2006) Syncope as a symptom of non-massive pulmonary embolism: a case report. Internal and Emergency Medicine 1:2, 167-170
    CrossRef

  142. 142

    Nikhil Goyal, Michael W. Donnino, Ravi Vachhani, Ravi Bajwa, Tabassum Ahmad, Ronny Otero. (2006) The utility of head computed tomography in the emergency department evaluation of syncope. Internal and Emergency Medicine 1:2, 148-150
    CrossRef

  143. 143

    Paul A Gould, Andrew D Krahn, George J Klein, Raymond Yee, Allan C Skanes, Lorne J Gula. (2006) Investigating syncope: a review. Current Opinion in Internal Medicine 5:2, 159-166
    CrossRef

  144. 144

    Jeffrey W. Britton, Eduardo Benarroch. (2006) Seizures and syncope:. Clinical Autonomic Research 16:1, 18-28
    CrossRef

  145. 145

    Youichi Kobayashi. (2006) Diagnosis and Treatment of Syncope. Journal of Arrhythmia 22:2, 74-85
    CrossRef

  146. 146

    Richard G. Sheahan. 2006. Síncope cardíaco. , 214-220.
    CrossRef

  147. 147

    R. Winker, M. Frühwirth, P. Saul, H. W. Rüdiger, T. Pezawas, H. Schmidinger, M. Moser. (2006) Prolonged asystole provoked by head-up tilt testing. Clinical Research in Cardiology 95:1, 42-47
    CrossRef

  148. 148

    Maw Pin Tan, Rose Anne Kenny. (2006) Cardiovascular assessment of falls in older people. Clinical Interventions in Aging 1:1, 57-66
    CrossRef

  149. 149

    Gonzalo Barón-Esquivias, Silvia Gómez, Aurelio Cayuela, Juan I. Valle, Alonso Pedrote, Ángel Martínez. (2006) Análisis de la respuesta al test de tabla basculante de los pacientes con síncope que presentan hipertensión arterial. Revista Española de Cardiología 59:1, 68-71
    CrossRef

  150. 150

    EDUARDO BACK STERNICK, MARTINO MARTINELLI, ROGERIO CORREIA SAMPAIO, LUIZ MARCIO GERKEN, RICARDO ALKMIM TEIXEIRA, RICARDO SCARPELLI, MAURICIO SCANAVACCA, SILVANA D'ORIO NISHIOKA, EDUARDO SOSA. (2005) Sudden Cardiac Death in Patients with Chagas Heart Disease and Preserved Left Ventricular Function. Journal of Cardiovascular Electrophysiology 0:0, 051123074027004-???
    CrossRef

  151. 151

    Attilio Del Rosso, Paolo Alboni, Michele Brignole, Carlo Menozzi, Antonio Raviele. (2005) Relation of Clinical Presentation of Syncope to the Age of Patients. The American Journal of Cardiology 96:10, 1431-1435
    CrossRef

  152. 152

    S. A. Grossman, N. I. Shapiro, S. Van Epp, R. Kohen, R. Arnold, R. Moore, L. Lee, R. E. Wolfe, L. A. Lipsitz. (2005) Sex Differences in the Emergency Department Evaluation of Elderly Patients With Syncope. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 60:9, 1202-1205
    CrossRef

  153. 153

    Cabot, Richard C.Harris, Nancy Lee, Shepard, Jo-Anne O., Ebeling, Sally H.Ellender, Stacey M.Peters, Christine C., Binder, William D., Fifer, Michael A., King, Mary Etta, Stone, James R., . (2005) Case 26-2005. New England Journal of Medicine 353:8, 824-832
    Full Text

  154. 154

    Lisa Bourdeaux, Lori Matthews, Nancy Lee Richards, Grace SanAgustin, Patricia Thomas, Susan Veltigian. (2005) Comparative Study of Case Management Program for Patients With Syncope. Journal of Nursing Care Quality 20:2, 140-144
    CrossRef

  155. 155

    Greg C. Flaker. (2005) “Show-me” the money. Heart Rhythm 2:4, 374-375
    CrossRef

  156. 156

    José Mauricio Sánchez, William T. Katsiyiannis, Brian F. Gage, Jane Chen, Mitchell N. Faddis, Marye J. Gleva, Timothy W. Smith, Bruce D. Lindsay. (2005) Implantable cardioverter-defibrillator therapy improves long-term survival in patients with unexplained syncope, cardiomyopathy, and a negative electrophysiologic study. Heart Rhythm 2:4, 367-373
    CrossRef

  157. 157

    G. Klein, T. Korte. (2005) Differentialdiagnose Synkope. Intensivmedizin + Notfallmedizin 42:3, 290-298
    CrossRef

  158. 158

    Roland D. Thijs, David G. Benditt, Christopher J. Mathias, Ronald Schondorf, Richard Sutton, Wouter Wieling, J. Gert Dijk. (2005) Unconscious Confusion. Clinical Autonomic Research 15:1, 35-39
    CrossRef

  159. 159

    Koichi Mizumaki, Akira Fujiki, Masao Sakabe, Kunihiro Nishida, Masataka Sugao, Takayuki Tsuneda, Hidehiko Nagasawa, Hiroshi Inoue. (2005) Dynamic Changes in the QT-R-R Relationship during Head-Up Tilt Test in Patients with Vasovagal Syncope. Annals of Noninvasive Electrocardiology 10:1, 16-24
    CrossRef

  160. 160

    Yaron Bar-Dayan, Keren Elishkevits, Liav Goldstein, Avishay Goldberg, Nisim Ohana, Erez Onn, Yehezkel Levi, Yosefa Bar-Dayan. (2005) The Prevalence of Common Cardiovascular Diseases among 17-Year-Old Israeli Conscripts. Cardiology 104:1, 6-9
    CrossRef

  161. 161

    Philippe Bordier, Stephane Lanusse, Stephane Garrigue, Charlotte Reynard, Frederic Robert, Laurent Gencel, Alexia Lafitte. (2005) Causes of Syncope in Patients with Alzheimer???s Disease Treated with Donepezil. Drugs & Aging 22:8, 687-694
    CrossRef

  162. 162

    Jim W. Cheung, Kenneth M. Stein, Steven M. Markowitz, Sei Iwai, Amit B. Guttigoli, Bindi K. Shah, Ravi K. Yarlagadda, Bruce B. Lerman, Suneet Mittal. (2004) Significance of adenosine-induced atrioventricular block in patients with unexplained syncope. Heart Rhythm 1:6, 664-668
    CrossRef

  163. 163

    Roland D. Thijs, Wouter Wieling, Horacio Kaufmann, Gert Dijk. (2004) Defining and classifying syncope. Clinical Autonomic Research 14:S1, i4-i8
    CrossRef

  164. 164

    N. Colman, K. Nahm, K. S. Ganzeboom, W. K. Shen, J. Reitsma, M. Linzer, W. Wieling, H. Kaufmann. (2004) Epidemiology of reflex syncope. Clinical Autonomic Research 14:S1, i9-i17
    CrossRef

  165. 165

    Wouter Wieling, Nancy Colman, C. T. Paul Krediet, Roy Freeman. (2004) Nonpharmacological treatment of reflex syncope. Clinical Autonomic Research 14:S1, i62-i70
    CrossRef

  166. 166

    Christopher J. Mathias. (2004) Role of autonomic evaluation in the diagnosis and management of syncope. Clinical Autonomic Research 14:S1, i45-i54
    CrossRef

  167. 167

    Daniel P. Melby, Joseph A. Cytron, David G. Benditt. (2004) New approaches to the treatment and prevention of neurally mediated reflex (neurocardiogenic) syncope. Current Cardiology Reports 6:5, 385-390
    CrossRef

  168. 168

    Amy Desrochers DiVasta, Mark E Alexander. (2004) Fainting freshmen and sinking sophomores: cardiovascular issues of the adolescent. Current Opinion in Pediatrics 16:4, 350-356
    CrossRef

  169. 169

    ANDREW D. KRAHN, GEORGE J. KLEIN, ALLAN C. SKANES, RAYMOND YEE. (2004) Insertable Loop Recorder Use for Detection of Intermittent Arrhythmias. Pacing and Clinical Electrophysiology 27:5, 657-664
    CrossRef

  170. 170

    Rukmini Rajagopalan, Alfonso Perez, Zhan Ye, Mehmood Khan, Frederick T Murray. (2004) Pioglitazone is Effective Therapy for Elderly Patients with Type 2 Diabetes Mellitus. Drugs & Aging 21:4, 259-271
    CrossRef

  171. 171

    SUNEET MITTAL, BRUCE B. LERMAN. (2003) Tilt Testing:. On the Road to Obsolescence?. Journal of Cardiovascular Electrophysiology 14:9, 925-926
    CrossRef

  172. 172

    TOH Jongh, JG Dijk. (2003) Wegraking. Huisarts en Wetenschap 46:7, 517-522
    CrossRef

  173. 173

    N Colman, RPJM Scholten, JB Reitsma, WK Shen, W Wieling, Nancy Colman. 2003. Drugs and pacemakers for neurally mediated reflex syncope. .
    CrossRef

  174. 174

    William H. Frishman, Victor Azer, Domenic Sica. (2003) Drug Treatment of Orthostatic Hypotension and Vasovagal Syncope. Heart Disease 5:1, 49-64
    CrossRef

  175. 175

    Maisel, William H., Stevenson, William G., . (2002) Syncope — Getting to the Heart of the Matter. New England Journal of Medicine 347:12, 931-933
    Full Text